Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 4;7(3):39.
doi: 10.3390/diagnostics7030039.

Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy

Affiliations
Review

Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy

Rabia Sannam Khan et al. Diagnostics (Basel). .

Abstract

Salivary diagnostics is an emerging field for the encroachment of point of care technology (PoCT). The necessity of the development of point-of-care (PoC) technology, the potential of saliva, identification and validation of biomarkers through salivary diagnostic toolboxes, and a broad overview of emerging technologies is discussed in this review. Furthermore, novel advanced techniques incorporated in devices for the early detection and diagnosis of several oral and systemic diseases in a non-invasive, easily-monitored, less time consuming, and in a personalised way is explicated. The latest technology detection systems and clinical utilities of saliva as a liquid biopsy, electric field-induced release and measurement (EFIRM), biosensors, smartphone technology, microfluidics, paper-based technology, and how their futuristic perspectives can improve salivary diagnostics and reduce hospital stays by replacing it with chairside screening is also highlighted.

Keywords: biomarkers; diagnostic toolboxes; diseases; saliva; the point of care.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Depiction of the detection of various oral and systemic diseases through salivary biomarkers. Acquired Immuno Defeciency Syndrome (AIDS), Human Papilloma Virus (HPV), Myocardial infarction (MI), Chronic Obstructive Pulmonary Disease (COPD), Sexually Transmitted Infection (STI), End Stage Renal Failure (ESRD) and Oral Squamous Muccous Fibrosis (OSMF).
Figure 2
Figure 2
Illustration of a range of promising emerging methods of PoC technologies.

Similar articles

Cited by

References

    1. St John A., Price C.P. Existing and emerging technologies for point-of-care testing. Clin. Biochem. Rev. Aust. Assoc. Clin. Biochem. 2014;35:155–167. - PMC - PubMed
    1. Jani I.V., Peter T.F. How point-of-care testing could drive innovation in global health. New Engl. J. Med. 2013;368:2319–2324. doi: 10.1056/NEJMsb1214197. - DOI - PubMed
    1. Shetty V., Yamaguchi M. Salivary biosensors for screening trauma-related psychopathology. Oral Maxillofac. Surg. Clin. North Am. 2010;22:269–278. doi: 10.1016/j.coms.2010.01.004. - DOI - PMC - PubMed
    1. Khanna P., Walt D.R. Salivary diagnostics using a portable point-of-service platform: A review. Clin. Ther. 2015;37:498–504. doi: 10.1016/j.clinthera.2015.02.004. - DOI - PMC - PubMed
    1. Khurshid Z., Zohaib S., Najeeb S., Zafar M., Rehman R., Rehman I. Advances of proteomic sciences in dentistry. Int. J. Mol. Sci. 2016;17:728. doi: 10.3390/ijms17050728. - DOI - PMC - PubMed

LinkOut - more resources